Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").
CiteScore measures average citations received per document published in the serial.
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
Overview | |
Publisher | BENTHAM SCIENCE PUBL LTD |
Language | English |
Frequency | Bi-monthly |
General Details | |
Language | English |
Frequency | Bi-monthly |
Publication Start Year | 2000 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper1.1k articles received 21.3k citations see all
Current Gene Therapy has been in operation since 2000 till date.
Current Gene Therapy published with a Bi-monthly frequency.
In 2024, Current Gene Therapy published 62 articles.
For Current Gene Therapy,eISSN is 1875-5631 and pISSN is1566-5232.
Citescore for Current Gene Therapy is 5.8.
SNIP score for Current Gene Therapy is 0.89.
SJR for Current Gene Therapy is Q3.
BENTHAM SCIENCE PUBL LTD is the publisher of Current Gene Therapy.